2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Invasive Pulmonary Aspergillosis: new trials by email Literature Review of Invasive Pulmonary Aspergillosis trials Research Report on Invasive Pulmonary Aspergillosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate Safety and Efficacy of the Coadministration of Ibrexafungerp With Voriconazole in Patients With Invasive Pulmonary Aspergillosis SCY-078, Voriconazole, Oral Placebo Tablets - Invasive Pulmonary Aspergillosis | Phase 2 | Terminated | Scynexis, Inc. | 22 | 2019-01-22 | 2024-08-09 |
| VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults Investigational Agent: VL-2397, Standard treatment: Voriconazole, Isavuconazole, or Liposomal amphotericin B - Invasive Aspergillosis, Invasive Pulmonary Aspergillosis | Phase 2 | Terminated | Vical | 4 | 2018-02-20 | 2019-02-27 |
Aspergillosis (1)
Bacterial Infections and Mycoses (2) · Infections (2) · Invasive Fungal Infections (2) · Lung Diseases (2) · Lung Diseases, Fungal (2) · Mycoses (2) · Pulmonary Aspergillosis (2) · Respiratory Tract Diseases (2) · Aspergillosis (1)
Voriconazole (1) · ibrexafungerp (1) · isavuconazole (1) · liposomal amphotericin B (1)
Scynexis, Inc. (1) · Vical (1)
Belgium (2) · Canada (2) · Germany (2) · United States (2) · France (1) · South Africa (1) · South Korea (1)
David Angulo, MD (1) · Mammen P Mammen, MD, FIDSA (1)
2017 (1), 2018 (1)